Australia vs New Zealand: Proportion of isolates with decreased susceptibility or resistance
Australia
0.0666
in 2018
New Zealand
0.4386
in 2017
Australia rank
24th
New Zealand rank
22nd
Proportion of isolates with decreased susceptibility or resistance over time
- Australia
- New Zealand
How they compare
New Zealand currently reports 0.4386 against 0.0666 in Australia, a difference of 0.372.
That makes New Zealand's figure about 6.6 times Australia's.
The two have swapped places 5 times across 9 shared years of data; in 2009 it was Australia ahead.
Australia ranks 24th and New Zealand ranks 22nd of 51 countries.
Australia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0317 | 0 | 0.0317 | Australia |
| 2010s | 0.4418 | 0.3595 | 0.0822 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Australia or New Zealand?
- New Zealand, at 0.4386 against 0.0666 in Australia as of 2017.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Australia and New Zealand?
- 0.372, with New Zealand ahead.
- How many years of comparable data are there for Australia and New Zealand?
- 9 years are reported by both, from 2009 to 2017.
- How do Australia and New Zealand rank globally for proportion of isolates with decreased susceptibility or resistance?
- Australia ranks 24th and New Zealand ranks 22nd of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.